IV is a common way around low oral bioavailability.
Furthermore, you can tweak the oral delivery system.
I would assume that injecting directly into the digestive system is not practical (invasive) and they'd be very aware of that.
Let's not overthink this ....
BOT - Anything but charting, page-101
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.005(1.85%) |
Mkt cap ! $421.3M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.5¢ | $760.5K | 2.837M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 1369745 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 359072 | 10 |
View Market Depth
| Last trade - 14.11pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
-0.005 ( 3.02 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.5¢ | 26.0¢ | 2019700 | ||
| Last updated 14.33pm 15/05/2024 ? | |||||
| BOT (ASX) Chart |